共 29 条
[1]
Silver DA(1997)Prostate-specific membrane antigen expression in normal and malignant human tissues [eng] Clin Cancer Res 3 81-85
[2]
Pellicer I(2014)Targeting prostate-specific membrane antigen for personalized therapies in prostate cancer: morphologic and molecular backgrounds and future promises [eng] J Biol Regul Homeost Agents 28 555-563
[3]
Fair WR(2018)The Iranian Society of Nuclear Medicine practical guideline on radioligand therapy in metastatic castration-resistant prostate cancer using 177Lu-PSMA Iranian Journal of Nuclear Medicine 26 2-8
[4]
Heston WD(2016)Therapie mit 177Lu-PSMA-617, Dosimetrie und Nachsorge beim metastasierten kastrationsresistenten Prostatakarzinom. [177Lu-PSMA-617 therapy, dosimetry and follow-up in patients with metastatic castration-resistant prostate cancer] [ger] Nuklearmedizin 55 123-128
[5]
Cordon-Cardo C(2018)Discrete evaluation of multi-cycle Lu-177-PSMA-617-therapy effects on bone versus lymph node metastases in patients with metastasized castration-resistant prostate cancer (mCRPC) J Nucl Med 59 523-undefined
[6]
Santoni M(undefined)undefined undefined undefined undefined-undefined
[7]
Scarpelli M(undefined)undefined undefined undefined undefined-undefined
[8]
Mazzucchelli R(undefined)undefined undefined undefined undefined-undefined
[9]
Lopez-Beltran A(undefined)undefined undefined undefined undefined-undefined
[10]
Cheng L(undefined)undefined undefined undefined undefined-undefined